Replies to post #34866 on Revive Therapeutics Ltd (RVVTF)

[Ecomike]

No, it was not common sense when the trail was set up and approved. Back then it was about reduction of deaths, reduction of ICU cases, and reduction of hospital ER visits for covid19 infections.

Since then, 2 tings happened.

1) Covid19 mutated

2) People got clot shots (Vaccinated)

3) People got the new problem, Long Haul Covid19 that did not exist yet, when the trial was first applied for an approved.

4) The entire need changed. The good news, is the RVVTF drug is perfect for covid19 and long haul covid19

The awesome news is the FDA did not say Piss Off LOL

Sell if you want folks, lock in a loss. I will putting nets out this year and soaking up more shares now.

What makes you think "Why wouldn’t this have already been included with their proposed symptom relief endpoints?" was not in the proposed end points change request???

Or at least not set up in the request, so the FDA would come back and suggest it?

Some times it is smart to let others think it was their idea. LOLOL

[Ecomike]

I don't know what everyone is smoking, but that is a huge yes in my book, some (who shall remain nameless) said would not happen, and even said it was mistake to try/ask for...

“The FDA recommends that the Company’s proposed primary symptom-based endpoints should cover the evaluation of time to sustained recovery assessed over an appropriate duration, evidence of subjects experiencing resolution of COVID-19 related symptoms and the element of sustained symptom resolution”